German High Tech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alentis Therapeutics: Alentis Founder Receives Prestigious French Academy of Science Award Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading authority in the field, has been awarded the Mémain-Pelletier, French Academy of Science award for his ground-breaking research into understanding the pathogenesis of liver cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201222005253/en/ Professor Thomas Baumert, fou...

Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading authority in the field, has been awarded the Mémain-Pelletier, French Academy of Science award for his ground-breaking research into understanding the pathogenesis of liver cancer. Professor Thomas Baumert, founder of Alentis Therapeutics. Copyright Alentis Therapeutics Said Prof. Thomas Baumert: “It’s a great honor and a mark of recognition for my team, my colleagues and collaborators, some 50 in all. Now we are going ...